Improved CT Cardiac Images The Focus Of MEDRAD's Stellant(R) Presentation At RSNA
INDIANOLA, Pa., Nov. 17 /PRNewswire/ -- Improved CT diagnostic images of the coronary arteries are possible with fewer artifacts; this is the focus of MEDRAD's live booth presentation of the Stellant(R) CT Injection System at the 2004 Annual Meeting of the Radiological Society of North America (RSNA). The presentation will repeat every hour and offer clinical information, real-world examples, physician testimonials, and product demos on how to achieve better CT imaging results with DualFlow(TM) Simultaneous Injection (Booth #1929, South Building).
(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )
Stellant is designed to meet the latest clinical, safety and ease-of-use requirements of rapidly evolving computed tomography (CT) technology. The Stellant D with the DualFlow(TM) option enables both contrast and saline injection at the same time through variable ratios of simultaneous plunger motion. With the proper ratio and timing, left and right heart ventricles can be illuminated uniformly.
"Stellant is a prime example of MEDRAD's commitment to product innovation, and clinicians have responded enthusiastically," according to Cliff Kress, senior vice president of the MEDRAD CT Strategic Business Unit. "DualFlow's contribution to diagnostic capabilities, combined with the rapid growth in complicated CTA and CT Cardiac procedures, creates a very valuable solution for our customers."
Designed with input from radiology thought leaders around the world, Stellant also features a pressure monitor graph, improved syringe design, syringe auto load and the ability to upgrade from single to dual injection.
MEDRAD, Inc. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and accessory products, and equipment services. Total 2003 revenues were $294 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a U.S. affiliate of Schering AG, Germany . For more information, visit MEDRAD's website at http://www.medrad.com/ .
Cautionary statement regarding forward-looking statements.
Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events, circumstances or otherwise.
Photo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comMEDRAD, Inc.CONTACT: Luanne Radermacher, Corporate Communications, +1-412-767-2400,ext. 3184, or lradermacher@medrad.com , or Dan Dieter, Marketing Services,+1-412-767-2400 ext. 3726, or ddieter@medrad.com , both of MEDRAD, Inc.